Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis (ALS)

Explore clinical trials studying Amyotrophic Lateral Sclerosis (ALS). Study availability and eligibility vary by location and protocol.

101 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis (ALS) trial results

Completed

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease

NCT01776970

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +21 more
Locations
  • San Raffaele Scientific Institute Milan, Italy
  • Fondazione Salvatore Maugeri IRCCS, Istituto Scientifico Milan, Italy
  • NEuroMuscular Omnicentre (NEMO), Fondazione Serena - H Cà granda Milan, Italy
  • Universita' Degli Studi Di Padova, Azienda Ospedaliera Di Padova, Neurologic Department; Padova, Italy
View Trial Details
Completed

PET Imaging in ALS Patients

NCT02236897

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00403104

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • L. Boltzmann Forschungsinstitut, Neurologische Abteilung, Kaiser Franz Josef Hospital, Wien Vienna, Austria
  • UCL Saint-Luc Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
View all 26 locations
View Trial Details
Completed

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

NCT00694941

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Prof. Maloteaux, UCL Saint-Luc Brussels, Belgium
  • Prof. Wim Robberecht, UZ Leuven Leuven, Belgium
  • Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
  • Prof. Philippe Couratier, Hopital Duruytren Limoges, France
View all 25 locations
View Trial Details
Completed

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

NCT00244244

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

NCT06643481

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Loma Linda University Health Loma Linda, California, United States
  • Keck Medical Center USC Los Angeles, California, United States
  • UC San Francisco Medical Center San Francisco, California, United States
View all 74 locations
View Trial Details

Related conditions